The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

Ozempic, a popular drug for treating diabetes and promoting weight loss, has emerged as an unexpected weapon in the fight ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Ozempic, a diabetes medication by Novo Nordisk, has gained popularity for its weight loss effects, sparking debate.

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

In response to a lawsuit, the FDA said it would reconsider its previous decision to remove tirzepatide, the active compound ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...